Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
Oncogenic RAS mutants are key anti-cancer targets as KRas mutations are very frequent in human cancers. Here, the authors engineer a cytosol-penetrating anti-Ras antibody and demonstrate its ability to block RAS-effector protein interactions inhibiting tumour growth of Ras mutant-driven cancers.
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f92bfa18577140acbe2a6429590c88a9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|